BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29751134)

  • 1. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
    Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
    Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
    Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
    Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
    Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
    Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):779-787.e2. PubMed ID: 33317785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
    Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.
    Tsubokawa N; Mimura T; Tadokoro K; Yamashita Y
    Jpn J Clin Oncol; 2022 Aug; 52(8):917-924. PubMed ID: 35438159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
    Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer.
    Hervochon R; Bobbio A; Guinet C; Mansuet-Lupo A; Rabbat A; Régnard JF; Roche N; Damotte D; Iannelli A; Alifano M
    Ann Thorac Surg; 2017 Jan; 103(1):287-295. PubMed ID: 27659598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
    Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
    Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes.
    Nakamura R; Yoneyama S; Tobita R; Kurihara S; Hatori T; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Satoh H; Inage Y
    Anticancer Res; 2022 Jun; 42(6):3159-3168. PubMed ID: 35641288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.